Tens of thousands of central venous catheters are inserted into the veins of newborns in Australian ICU settings every year for essential intravascular access and delivery of life-saving therapies – with many more required for older children.
Correct catheter tip positioning is vital to avoid serious and potentially life-threatening complications. Catheter insertion is currently performed ‘with no real-time navigation’, resulting in low success rates on post-procedure X-ray. As many as 50 per cent of catheters end up in sub-optimal locations after placement or move within a week, exposing patients to potentially dangerous complications.
Navi is developing the Neonav® ECG Tip Location System (‘Neonav’) to improve the standard-of-care for critically-ill children by providing clinicians fast, easy-to-use, real-time confirmation of catheter tip location during its insertion to increase the number of ‘first-time-right’ central vascular catheter placement procedures, and confirm that the tip remains in a safe position for continued use post-procedure. The Neonav will improve quality-of-care by reducing procedure time and ionising radiation exposure, improve clinical decision-making by identifying catheter migration to avoid complications, and provide significant cost-savings to hospitals.
This clinical stage project, through the CTCM grant, will achieve a critical step in delivering the world’s first ECG tip location system designed for paediatric patients by completing device development, manufacture, and a pilot clinical translation trial. The CTCM grant will be instrumental for the Neonav’s successful technology translation and commercialisation which has a global market and improve the standard of care for newborns and children.
CTCM Project Round: One
State: VIC
Project Partner: The Royal Women’s Hospital
Funding:
Website: Navi Medical Technologies | LinkedIn: Navi Medical Technologies
Twitter: @NaviMedTech
